CRS associated with CAR T cells, neurotoxicity

Chimeric antigen receptor (CAR) T cell therapy is an exciting and rapidly advancing area in cancer immunology. In clinical trials, CAR T cell therapy has shown unprecedented efficacy in the management of hematologic malignancies and…